Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,352.00    -49.50 (-1.12%)
Bid:
4,353.50
Ask:
4,354.00
Spread: 0.50 (0.011%)
Market Cap: £94.24b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Share Buy-Back Programme

30 Apr 2026 07:01

RNS Number : 5598C
Unilever PLC
30 April 2026
 

2026 Share Buyback

 

London, 30 April 2026. Unilever PLC ("Unilever") announces that it is today commencing a new share buyback of up to €1.5 billion (the "SBB"), as set out in its full year 2025 results on 12 February 2026 and reiterated in its first quarter trading statement released today.

The purpose of the SBB is to reduce the capital of Unilever and it will take place within the limitations of the authority granted to the Board of Unilever by its general meeting held on 30 April 2025 (as amended at the general meeting held on 21 October 2025 relating to the share consolidation of Unilever shares). Accordingly, the maximum number of shares to be bought back by Unilever is 223,263,040.

The SBB commences today, 30 April 2026, and will end on or before 6 July 2026.

Any repurchases of shares under the SBB are expected to be announced on a weekly basis and in any event will be announced no later than the end of the seventh trading day following the date of the repurchase.

Unilever has entered into non-discretionary instructions with Morgan Stanley & Co. International PLC to conduct the SBB on its behalf and to make trading decisions under the SBB independently of Unilever.

 

ENDS

 

Enquiries

Media:

Unilever Press Office

press-office.london@unilever.com

Investors:

Investor Relations Team investor.relations@unilever.com 

 

About Unilever

Unilever is a global consumer goods business comprised of four business groups: Beauty & Wellbeing, Personal Care, Home Care and Foods. Unilever's products are used by approximately 3.7 billion people every day, with sales in around 190 countries. We have around 96,000 employees and generated sales of €50.5 billion in 2025.

For more information about Unilever and our brands, please visit www.unilever.com.

 

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to Unilever's share buyback, its purpose and timetable. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', 'ambition', 'target', 'goal', 'plan', 'potential', 'work towards', 'may', 'milestone', 'objectives', 'outlook', 'probably', 'project', 'risk', 'seek', 'continue', 'projected', 'estimate', 'achieve' or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this announcement. Readers should not place undue reliance on forward-looking statements.

Because these forward-looking statements involve known and unknown risks and uncertainties, a number of which may be beyond the Group's control, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. The forward-looking statements are based on our beliefs, assumptions and expectations regarding anticipated developments and other factors affecting the Group, taking into account all information currently available to us. They are not historical facts, nor are they guarantees of future performance or outcomes. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this announcement. Readers should not place undue reliance on forward-looking statements.

The forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. New risks and uncertainties arise over time, and it is not possible for us to predict those events or how they may affect us. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2025 and the Unilever Annual Report and Accounts 2025 available on our corporate website www.unilever.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGSGDSBUXDGLG
Date   Source Headline
25th Oct 20245:09 pmRNSTransaction in Own Shares
24th Oct 20245:12 pmRNSTransaction in Own Shares
24th Oct 20247:00 amRNSQ3 2024 Trading Statement
23rd Oct 20245:22 pmRNSTransaction in Own Shares
22nd Oct 20245:14 pmRNSTransaction in Own Shares
21st Oct 20245:16 pmRNSTransaction in Own Shares
18th Oct 20245:28 pmRNSTransaction in Own Shares
17th Oct 20245:08 pmRNSTransaction in Own Shares
16th Oct 20245:12 pmRNSTransaction in Own Shares
15th Oct 20245:14 pmRNSTransaction in Own Shares
14th Oct 20245:13 pmRNSTransaction in Own Shares
11th Oct 20245:31 pmRNSTransaction in Own Shares
10th Oct 20245:18 pmRNSTransaction in Own Shares
9th Oct 20245:09 pmRNSTransaction in Own Shares
8th Oct 20245:15 pmRNSTransaction in Own Shares
3rd Oct 20245:31 pmRNSTransaction in Own Shares
1st Oct 20245:09 pmRNSTransaction in Own Shares
1st Oct 20242:09 pmRNSTotal Voting Rights
30th Sep 20245:26 pmRNSTransaction in Own Shares
25th Sep 20245:16 pmRNSTransaction in Own Shares
23rd Sep 20245:56 pmRNSTransaction in Own Shares
20th Sep 20245:19 pmRNSTransaction in Own Shares
19th Sep 20245:21 pmRNSTransaction in Own Shares
18th Sep 20245:21 pmRNSTransaction in Own Shares
17th Sep 20245:15 pmRNSTransaction in Own Shares
16th Sep 20245:17 pmRNSTransaction in Own Shares
16th Sep 20242:42 pmRNSBlock listing Interim Review
13th Sep 20245:59 pmRNSTransaction in Own Shares
13th Sep 20245:02 pmRNSDirector/PDMR Shareholding
13th Sep 20243:51 pmRNSDirector/PDMR Shareholding
13th Sep 20247:00 amRNSShare Buyback Commencement of 2024 Second Tranche
11th Sep 20244:36 pmRNSDirector/PDMR Shareholding
11th Sep 202411:21 amRNSDirector/PDMR Shareholding
9th Sep 20245:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20243:14 pmRNSTotal Voting Rights - Correction
2nd Sep 20245:12 pmRNSTotal Voting Rights
30th Aug 20245:57 pmRNSCompletion of First Tranche of 2024 Share Buyback
30th Aug 20245:42 pmRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSTransaction in Own Shares
23rd Aug 20247:00 amRNSTransaction in Own Shares
22nd Aug 20247:00 amRNSTransaction in Own Shares
21st Aug 20247:00 amRNSTransaction in Own Shares
20th Aug 20247:00 amRNSTransaction in Own Shares
19th Aug 20247:00 amRNSTransaction in Own Shares
16th Aug 20247:00 amRNSTransaction in Own Shares
15th Aug 20247:00 amRNSTransaction in Own Shares
14th Aug 202412:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.